US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PMGC Holdings

4.88

-0.2200-4.31%

Post-market: 4.77-0.1100-2.25%19:13 EDT

Volume:70.14K

Turnover:348.98K

Market Cap:2.82M

PE:-0.01

High:5.07

Open:4.87

Low:4.61

Close:5.10

Loading ...

Overview Company News Filings

Northstrive Biosciences Submits Pre-IND Request for EL-22

Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Announces Successful Submission of Pre-Ind Meeting Request to FDA for El-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1 Receptor Agonists

THOMSON REUTERS

Northstrive Biosciences- Pre-Ind Meeting With FDA Expected in Q2 2025

THOMSON REUTERS

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists

PMGC files to sell 969,386 shares of common stock for holders

Northstrive Biosciences Unveils Innovative Obesity Drug Candidates

Northstrive - Anticipates Type B Pre-Ind Meeting With FDA in Q2 2025

THOMSON REUTERS

Pmgc Unit, Northstrive, Says Preparing for FDA Investigational New Drug Filing for El-22

THOMSON REUTERS

Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1

BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's

Pmgc Capital Llc, a Subsidiary of Pmgc Holdings Inc., Begins to Build Portfolio With Strategic Acquisition of Shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

THOMSON REUTERS

PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies

Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Signs Agreement for Preclinical Mouse Study of El-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1

THOMSON REUTERS

Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1

3 Penny Stocks to Watch Now, 1/28/25

S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELAB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELAB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","market":"US","secType":"STK","nameCN":"PMGC Holdings","latestPrice":4.88,"timestamp":1743105600000,"preClose":5.1,"halted":0,"volume":70137,"hourTrading":{"tag":"盘后","latestPrice":4.77,"preClose":4.88,"latestTime":"19:13 EDT","volume":1693,"amount":8130.7976,"timestamp":1743117201738},"delay":0,"floatShares":543600,"shares":577500,"eps":-433.80963,"marketStatus":"Closed","change":-0.22,"latestTime":"03-27 16:00:00 EDT","open":4.87,"high":5.07,"low":4.61,"amount":348980.1588999,"amplitude":0.090196,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-433.80963,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743148800000},"marketStatusCode":5,"adr":0,"listingDate":1700542800000,"exchange":"NASDAQ","adjPreClose":5.1,"preHourTrading":{"tag":"盘前","latestPrice":5.06,"preClose":5.1,"latestTime":"09:19 EDT","volume":13557,"amount":71331.17227499999,"timestamp":1743081555135},"postHourTrading":{"tag":"盘后","latestPrice":4.77,"preClose":4.88,"latestTime":"19:13 EDT","volume":1693,"amount":8130.7976,"timestamp":1743117201738},"volumeRatio":0.050197},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELAB\",,,,,undefined,":{"symbol":"ELAB","floatShares":543600,"roa":"-48.26%","roe":"-130.35%","lyrEps":-560.406084,"volumeRatio":0.050197,"shares":577500,"dividePrice":0,"high":5.07,"amplitude":0.090196,"preClose":5.1,"low":4.61,"week52Low":3.88,"pbRate":"0.33","psRate":"1.15","week52High":1064,"institutionHeld":0,"latestPrice":4.88,"eps":-433.80963,"divideRate":0,"volume":70137,"delay":0,"ttmEps":-433.80963,"open":4.87,"prevYearClose":16.03,"prevWeekClose":4.93,"prevMonthClose":8.715,"prevQuarterClose":16.03,"fiveDayClose":6.4,"twentyDayClose":8.33,"sixtyDayClose":17.08},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELAB\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512437819","title":"Northstrive Biosciences Submits Pre-IND Request for EL-22","url":"https://stock-news.laohu8.com/highlight/detail?id=2512437819","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512437819?lang=en_us&edition=fundamental","pubTime":"2025-02-20 05:34","pubTimestamp":1740000891,"startTime":"0","endTime":"0","summary":"ELEVAI Labs Inc. ( ($ELAB) ) has provided an announcement. On February 18, 2025, Northstrive Biosciences announced the successful submission of a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-submits-pre-ind-request-for-el-22?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-submits-pre-ind-request-for-el-22?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU2552382132.HKD","LU2552382058.USD","BK4183","BK4585","BK4588","BK4558","LU2404859667.USD","EL","LU2552382215.SGD","BK4504","ELAB","LU2404859741.USD","BK4548","LU0690374615.EUR","LU0690374961.EUR"],"gpt_icon":0},{"id":"2512815677","title":"Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Announces Successful Submission of Pre-Ind Meeting Request to FDA for El-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1 Receptor Agonists","url":"https://stock-news.laohu8.com/highlight/detail?id=2512815677","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512815677?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:01","pubTimestamp":1739880074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P80ZZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2512567291","title":"Northstrive Biosciences- Pre-Ind Meeting With FDA Expected in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2512567291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512567291?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:01","pubTimestamp":1739880074,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nFWN3P80ZZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2512823159","title":"Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Announces Successful Submission of Pre-IND Meeting Request to FDA for EL-22, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1 Receptor Agonists","url":"https://stock-news.laohu8.com/highlight/detail?id=2512823159","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512823159?lang=en_us&edition=fundamental","pubTime":"2025-02-18 20:00","pubTimestamp":1739880000,"startTime":"0","endTime":"0","summary":"Northstrive Biosciences Inc. (“Northstrive Biosciences”) has submitted a pre-Investigational New Drug (“pre-IND”) meeting request to the U.S. Food and Drug Administration (“FDA”) for EL-22, a novel my","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3027670/0/en/Northstrive-Biosciences-Inc-a-Subsidiary-of-PMGC-Holdings-Inc-Announces-Successful-Submission-of-Pre-IND-Meeting-Request-to-FDA-for-EL-22-a-Potential-Breakthrough-Obesity-Therapy-T.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0690374961.EUR","BK4183","BK4533","LU2552382215.SGD","BK4144","EL","GLP","BK4548","LU0690374615.EUR","LU2404859741.USD","BK4585","BK4558","LU2552382132.HKD","LU2404859667.USD","BK4588","LU2552382058.USD","BK4590","BK4504","ELAB"],"gpt_icon":0},{"id":"2510327186","title":"PMGC files to sell 969,386 shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2510327186","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510327186?lang=en_us&edition=fundamental","pubTime":"2025-02-12 19:25","pubTimestamp":1739359510,"startTime":"0","endTime":"0","summary":"06:24 EST PMGC (ELAB) files to sell 969,386 shares of common stock for holders Published first on TheFly – the ultimate source for real-time, marke...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/pmgc-files-to-sell-969386-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/pmgc-files-to-sell-969386-shares-of-common-stock-for-holders?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2509774879","title":"Northstrive Biosciences Unveils Innovative Obesity Drug Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2509774879","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509774879?lang=en_us&edition=fundamental","pubTime":"2025-02-08 05:32","pubTimestamp":1738963976,"startTime":"0","endTime":"0","summary":"An update from ELEVAI Labs Inc. ( ($ELAB) ) is now available. On February 7, 2025, Northstrive Biosciences presented its innovative obesity drug ca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-unveils-innovative-obesity-drug-candidates?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/northstrive-biosciences-unveils-innovative-obesity-drug-candidates?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2508456532","title":"Northstrive - Anticipates Type B Pre-Ind Meeting With FDA in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456532?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:01","pubTimestamp":1738674099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nFWN3OV165:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELAB","BK4183"],"gpt_icon":0},{"id":"2508456306","title":"Pmgc Unit, Northstrive, Says Preparing for FDA Investigational New Drug Filing for El-22","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456306?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:01","pubTimestamp":1738674099,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nFWN3OV165:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2508245654","title":"Northstrive Biosciences, Inc., a Subsidiary of PMGC Holdings Inc., Reports Positive Updates for Obesity Drug Candidates Targeting Fat Loss and Muscle Preservation used in Combination with GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2508245654","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508245654?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:00","pubTimestamp":1738674000,"startTime":"0","endTime":"0","summary":"Lead asset EL-22 is leveraging a myostatin-engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.Northstrive Biosciences Inc. is preparing the necessary steps to leverage existing EL-22 animal data and human safety studies from Korean licensing partner to arrange an Investigational New Drug filing with the U.S. Food and Drug Administration.EL-32 is a pre-clinical, engineered probiotic expressing dual myostatin & activin-A, focusing on two clinically validated targets that play an important role in regulating muscle.NEWPORT BEACH, Calif., Feb. 04, 2025  -- Northstrive Biosciences Inc. , a subsidiary of PMGC Holdings Inc.  , announced an update for its innovative obesity treatment candidates, EL-22 and EL-32, both aimed at optimizing fat loss while preserving muscle mass in patients undergoing weight loss therapies, including GLP-1 receptor agonists.Upon regulatory confirmation, Northstriv","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-inc-subsidiary-pmgc-130000839.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4183","BK4590","BK4144","ELAB","GLP"],"gpt_icon":1},{"id":"2508962253","title":"BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co's","url":"https://stock-news.laohu8.com/highlight/detail?id=2508962253","media":"Reuters","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508962253?lang=en_us&edition=fundamental","pubTime":"2025-02-01 00:21","pubTimestamp":1738340464,"startTime":"0","endTime":"0","summary":"BRIEF-PMGC Capital Builds Portfolio with Acquisition Of US Focused Uranium Energy & Fire Prevention Tech Co'sJan 31 (Reuters) - PMGC Holdings Inc ELAB.O:PMGC CAPITAL LLC, A SUBSIDIARY OF PMGC HOLDINGS","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2507612309","title":"Pmgc Capital Llc, a Subsidiary of Pmgc Holdings Inc., Begins to Build Portfolio With Strategic Acquisition of Shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2507612309","media":"THOMSON REUTERS","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507612309?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:35","pubTimestamp":1738337726,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250131:nFWN3OR0RJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2507296128","title":"PMGC Capital LLC, a subsidiary of PMGC Holdings Inc., Begins to Build Portfolio with Strategic Acquisition of shares in U.S.-Focused Uranium Energy and Fire Prevention Technology Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2507296128","media":"GlobeNewswire","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507296128?lang=en_us&edition=fundamental","pubTime":"2025-01-31 23:33","pubTimestamp":1738337580,"startTime":"0","endTime":"0","summary":"NEWPORT BEACH, Calif., Jan.  31, 2025  (GLOBE NEWSWIRE) -- PMGC Holdings Inc. (the “Company” or “PMGC”) (Nasdaq: ELAB) is pleased to announce that its operating investment division, PMGC Capital LLC, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/31/3018887/0/en/PMGC-Capital-LLC-a-subsidiary-of-PMGC-Holdings-Inc-Begins-to-Build-Portfolio-with-Strategic-Acquisition-of-shares-in-U-S-Focused-Uranium-Energy-and-Fire-Prevention-Technology-Compa.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UEC","BK4156","BGSX","ELAB"],"gpt_icon":0},{"id":"2507864078","title":"Northstrive Biosciences Inc., a Subsidiary of Pmgc Holdings Inc., Signs Agreement for Preclinical Mouse Study of El-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination With Glp-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2507864078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507864078?lang=en_us&edition=fundamental","pubTime":"2025-01-30 21:00","pubTimestamp":1738242002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nTUA3MNNS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2507707640","title":"Northstrive Biosciences Inc., a Subsidiary of PMGC Holdings Inc., Signs Agreement For Preclinical Mouse Study of EL-32, a Potential Breakthrough Obesity Therapy Targeting Fat Loss and Muscle Preservation in Combination with GLP-1","url":"https://stock-news.laohu8.com/highlight/detail?id=2507707640","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507707640?lang=en_us&edition=fundamental","pubTime":"2025-01-30 21:00","pubTimestamp":1738242000,"startTime":"0","endTime":"0","summary":"Groundbreaking research to evaluate the effects of EL-32, alone and in combination with semaglutide, on glycemic control and body composition in diet-induced obese mice.NEWPORT BEACH, Calif., Jan. 30, 2025  -- PMGC Holdings Inc.   , today announced that its subsidiary, Northstrive Biosciences Inc. , has executed a research agreement  with a leading preclinical contract research organization  specializing in metabolic disorders. This Research Agreement will support a preclinical study carried out by the CRO and designed to evaluate EL-32, a novel engineered probiotic, as a monotherapy and in combination with the GLP-1 receptor agonist semaglutide, focusing on its impact on glycemic control and body composition in diet-induced obese  mice. Pursuant to the research agreement, within three months of completion of this study, the CRO will provide results of this study to Northstrive Biosciences and deliver a report to Northstrive Biosciences describing the work envisaged in the Research Agr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/northstrive-biosciences-inc-subsidiary-pmgc-130000622.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4548","LU2404859667.USD","BK4590","LU2552382058.USD","LU0690374961.EUR","LU2552382132.HKD","LU2404859741.USD","BK4533","BK4588","BK4585","BK4504","LU0690374615.EUR","BK4558","BK4144","BK4183","LU2552382215.SGD","GLP","ELAB","EL"],"gpt_icon":0},{"id":"2506537560","title":"3 Penny Stocks to Watch Now, 1/28/25","url":"https://stock-news.laohu8.com/highlight/detail?id=2506537560","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506537560?lang=en_us&edition=fundamental","pubTime":"2025-01-28 16:36","pubTimestamp":1738053360,"startTime":"0","endTime":"0","summary":"Nvni Group, Elevai Labs Inc., and Canoo are the 3 Penny Stocks to watch on January 28, 2025, based on TipRanks’ Penny Stock Screener tool. Penny st...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-28-25?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/3-penny-stocks-to-watch-now-1-28-25?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4183","ELAB"],"gpt_icon":0},{"id":"2506586505","title":"S&P 500 Falls Over 100 Points; Dada Nexus Shares Spike Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2506586505","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506586505?lang=en_us&edition=fundamental","pubTime":"2025-01-28 02:56","pubTimestamp":1738004212,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/01/43245892/sp-500-falls-over-100-points-dada-nexus-shares-spike-higher","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","TSYW.SI","MNQmain","BK4551","BK4509","BK4503","VOO","BK4183","BK4139",".IXIC","NVIW.SI","BK4526","BK4579","LU1880383366.USD","PSQ","USAW.SI","BK4557","USJW.SI","LU1688375341.USD","BK4585","TQQQ","BK4588","AKRO","SQQQ","BK4531",".SPX","BK4587","BK4563","BK4505","LU0244354667.USD","NQmain","SPY","BK4023","QLD","ALLK","DADA","LU1188198961.HKD","PCOM","09618","BK4155","JD","VERU","JG","BK4584","LU0106959298.USD","ELAB","IE00BGV7N243.SGD","BK4504","QID"],"gpt_icon":1}],"pageSize":16,"totalPage":8,"pageCount":3,"totalSize":126}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELAB\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-10","symbol":"ELAB","defaultRemindTime":1741613400000,"type":"split","dateTimestamp":1741579200000,"forFactor":7,"toFactor":1,"ratio":7},{"market":"US","date":"2024-11-27","symbol":"ELAB","defaultRemindTime":1732717800000,"type":"split","dateTimestamp":1732683600000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELAB\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELAB\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELAB\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELAB","date":"2025-03-26","current":-0.783252,"percent":0.834395,"low":-19.933298,"twenty":-3.338783,"median":-1.741819,"eighty":-0.955191,"high":-0.185003,"avg":-2.78173,"sd":3.239225,"marketCap":4283538},"quantilePoints":[{"date":"2023-11-24","current":-18.255744,"twenty":-17.959705,"median":-17.515646,"eighty":-17.071587,"marketCap":64119575},{"date":"2023-12-01","current":-13.864497,"twenty":-19.360956,"median":-18.255744,"eighty":-16.918634,"marketCap":48696218},{"date":"2023-12-08","current":-10.509387,"twenty":-18.255744,"median":-15.443372,"eighty":-11.703412,"marketCap":36912079},{"date":"2023-12-15","current":-8.308155,"twenty":-18.10279,"median":-11.940243,"eighty":-9.335099,"marketCap":31539899},{"date":"2023-12-22","current":-8.354717,"twenty":-17.34789,"median":-10.682077,"eighty":-8.450306,"marketCap":31716661},{"date":"2023-12-29","current":-8.216856,"twenty":-16.918634,"median":-10.164008,"eighty":-8.299025,"marketCap":31193307},{"date":"2024-01-05","current":-7.303872,"twenty":-15.709807,"median":-9.153506,"eighty":-8.280766,"marketCap":27727384},{"date":"2024-01-12","current":-8.125558,"twenty":-14.012516,"median":-8.832664,"eighty":-8.070779,"marketCap":30846714},{"date":"2024-01-19","current":-4.884465,"twenty":-13.479646,"median":-8.376629,"eighty":-7.906442,"marketCap":18542688},{"date":"2024-01-26","current":-3.42369,"twenty":-11.881035,"median":-8.330979,"eighty":-7.359564,"marketCap":12997211},{"date":"2024-02-02","current":-3.834533,"twenty":-11.486317,"median":-8.216856,"eighty":-4.738387,"marketCap":14556876},{"date":"2024-02-09","current":-2.921549,"twenty":-10.785691,"median":-8.079909,"eighty":-3.801666,"marketCap":11090953},{"date":"2024-02-16","current":-3.323718,"twenty":-10.440311,"median":-7.942961,"eighty":-3.414564,"marketCap":12617692},{"date":"2024-02-23","current":-3.218269,"twenty":-10.164008,"median":-7.897312,"eighty":-3.378041,"marketCap":12217378},{"date":"2024-03-01","current":-3.181749,"twenty":-9.179141,"median":-7.443102,"eighty":-3.218269,"marketCap":12078741},{"date":"2024-03-08","current":-3.378041,"twenty":-9.127872,"median":-4.975763,"eighty":-3.263918,"marketCap":12823915},{"date":"2024-03-15","current":-3.555616,"twenty":-8.855945,"median":-4.679044,"eighty":-3.323718,"marketCap":13498037},{"date":"2024-03-22","current":-3.491707,"twenty":-8.832664,"median":-3.834533,"eighty":-3.332848,"marketCap":13255422},{"date":"2024-03-28","current":-3.149795,"twenty":-8.668692,"median":-3.638241,"eighty":-3.254788,"marketCap":11957434},{"date":"2024-04-05","current":-2.739531,"twenty":-8.426843,"median":-3.539867,"eighty":-3.191975,"marketCap":11784138},{"date":"2024-04-12","current":-2.578785,"twenty":-8.359099,"median":-3.514988,"eighty":-3.15016,"marketCap":11092686},{"date":"2024-04-19","current":-2.356802,"twenty":-8.353987,"median":-3.494218,"eighty":-3.138017,"marketCap":10137824},{"date":"2024-04-26","current":-2.715358,"twenty":-8.317285,"median":-3.457927,"eighty":-2.966103,"marketCap":11680160},{"date":"2024-05-03","current":-2.840249,"twenty":-8.271636,"median":-3.430537,"eighty":-2.908834,"marketCap":12217378},{"date":"2024-05-10","current":-2.751214,"twenty":-8.225986,"median":-3.400866,"eighty":-2.810275,"marketCap":11834394},{"date":"2024-05-17","current":-2.439543,"twenty":-8.198597,"median":-3.378041,"eighty":-2.734696,"marketCap":11265982},{"date":"2024-05-24","current":-2.476318,"twenty":-8.139253,"median":-3.346086,"eighty":-2.649774,"marketCap":11435812},{"date":"2024-05-31","current":-2.456058,"twenty":-8.070779,"median":-3.333761,"eighty":-2.615446,"marketCap":11342250},{"date":"2024-06-07","current":-2.620224,"twenty":-8.03426,"median":-3.293818,"eighty":-2.590871,"marketCap":12100380},{"date":"2024-06-14","current":-2.536364,"twenty":-7.99774,"median":-3.211422,"eighty":-2.574044,"marketCap":11713111},{"date":"2024-06-21","current":-2.409546,"twenty":-7.933831,"median":-3.194759,"eighty":-2.543297,"marketCap":11127455},{"date":"2024-06-28","current":-2.408319,"twenty":-7.915572,"median":-3.18814,"eighty":-2.539819,"marketCap":11121788},{"date":"2024-07-05","current":-2.340001,"twenty":-7.897312,"median":-3.163489,"eighty":-2.517446,"marketCap":10806289},{"date":"2024-07-12","current":-2.148137,"twenty":-7.860792,"median":-3.149795,"eighty":-2.484198,"marketCap":9920249},{"date":"2024-07-15","current":-2.063455,"twenty":-7.842533,"median":-3.149795,"eighty":-2.476543,"marketCap":9529182},{"date":"2024-08-02","current":-1.8,"twenty":-7.824273,"median":-3.149795,"eighty":-2.472639,"marketCap":8312530},{"date":"2024-08-09","current":-1.490993,"twenty":-7.627068,"median":-3.134046,"eighty":-2.438304,"marketCap":6885510},{"date":"2024-08-16","current":-1.275527,"twenty":-7.359564,"median":-3.024259,"eighty":-2.416511,"marketCap":6059653},{"date":"2024-08-23","current":-0.996722,"twenty":-6.536966,"median":-2.921549,"eighty":-2.408074,"marketCap":4735130},{"date":"2024-08-30","current":-1.174958,"twenty":-5.249658,"median":-2.921549,"eighty":-2.362653,"marketCap":5581877},{"date":"2024-09-06","current":-1.375091,"twenty":-4.920984,"median":-2.840249,"eighty":-2.345852,"marketCap":6532648},{"date":"2024-09-13","current":-1.357574,"twenty":-4.774907,"median":-2.7913,"eighty":-2.312486,"marketCap":6449430},{"date":"2024-09-20","current":-1.33918,"twenty":-4.674479,"median":-2.751214,"eighty":-2.26391,"marketCap":6362050},{"date":"2024-09-27","current":-0.556488,"twenty":-4.272766,"median":-2.706294,"eighty":-1.721618,"marketCap":2643710},{"date":"2024-10-04","current":-0.825353,"twenty":-3.907572,"median":-2.663183,"eighty":-1.516044,"marketCap":3921009},{"date":"2024-10-11","current":-0.609011,"twenty":-3.809883,"median":-2.623475,"eighty":-1.448755,"marketCap":2893229},{"date":"2024-10-18","current":-0.543983,"twenty":-3.700324,"median":-2.618669,"eighty":-1.401366,"marketCap":2584301},{"date":"2024-10-25","current":-0.958273,"twenty":-3.624547,"median":-2.598328,"eighty":-1.356698,"marketCap":4552470},{"date":"2024-10-31","current":-0.965548,"twenty":-3.591497,"median":-2.58341,"eighty":-1.330061,"marketCap":4587034},{"date":"2024-11-08","current":-0.186042,"twenty":-3.543017,"median":-2.570883,"eighty":-1.290658,"marketCap":883831},{"date":"2024-11-15","current":-0.272307,"twenty":-3.520466,"median":-2.545057,"eighty":-1.259215,"marketCap":1293652},{"date":"2024-11-22","current":-1.912035,"twenty":-3.514988,"median":-2.532982,"eighty":-1.195453,"marketCap":10456757},{"date":"2024-11-29","current":-0.970216,"twenty":-3.514075,"median":-2.507089,"eighty":-1.176604,"marketCap":5306027},{"date":"2024-12-06","current":-0.979681,"twenty":-3.507684,"median":-2.495456,"eighty":-1.057426,"marketCap":5357793},{"date":"2024-12-13","current":-1.055406,"twenty":-3.495725,"median":-2.476318,"eighty":-1.052022,"marketCap":5771922},{"date":"2024-12-20","current":-1.320411,"twenty":-3.487233,"median":-2.449166,"eighty":-1.053364,"marketCap":7221213},{"date":"2024-12-27","current":-1.354124,"twenty":-3.469339,"median":-2.436446,"eighty":-1.055406,"marketCap":7405585},{"date":"2025-01-03","current":-1.393455,"twenty":-3.460209,"median":-2.417636,"eighty":-1.071656,"marketCap":7620685},{"date":"2025-01-10","current":-1.18556,"twenty":-3.45108,"median":-2.415433,"eighty":-1.087177,"marketCap":6483728},{"date":"2025-01-17","current":-1.208035,"twenty":-3.441037,"median":-2.409546,"eighty":-1.102066,"marketCap":6606642},{"date":"2025-01-24","current":-1.112516,"twenty":-3.431907,"median":-2.407092,"eighty":-1.109145,"marketCap":6084256},{"date":"2025-01-31","current":-0.955191,"twenty":-3.419127,"median":-2.368422,"eighty":-1.085209,"marketCap":5223856},{"date":"2025-02-07","current":-1.039472,"twenty":-3.407716,"median":-2.352273,"eighty":-1.05223,"marketCap":5684785},{"date":"2025-02-14","current":-0.955191,"twenty":-3.391736,"median":-2.340001,"eighty":-1.033105,"marketCap":5223856},{"date":"2025-02-21","current":-0.915859,"twenty":-3.378041,"median":-2.326586,"eighty":-0.998824,"marketCap":5008756},{"date":"2025-02-28","current":-0.668633,"twenty":-3.378041,"median":-2.304429,"eighty":-0.984457,"marketCap":3656699},{"date":"2025-03-07","current":-0.406293,"twenty":-3.378041,"median":-2.256137,"eighty":-0.973171,"marketCap":2221982},{"date":"2025-03-14","current":-0.413918,"twenty":-3.37165,"median":-2.063455,"eighty":-0.968145,"marketCap":2263682},{"date":"2025-03-21","current":-0.675785,"twenty":-3.34426,"median":-1.851285,"eighty":-0.96081,"marketCap":3695808},{"date":"2025-03-26","current":-0.783252,"twenty":-3.338783,"median":-1.741819,"eighty":-0.955191,"marketCap":4283538}],"updateTime":1743091239587}}}